Open AccessPB1887: NETWORK META‐ANALYSIS OF PROGRESSION FREE SURVIVAL IN THE TREATMENT OF RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
Author(s) -
ChananKhan A.,
Liu T.,
Yang K.,
Cohen A.,
Fahrbach K.,
Campbell J.,
Tang B.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000850400.19760.77
Subject(s) - ibrutinib , medicine , oncology , chronic lymphocytic leukemia , bendamustine , hazard ratio , progression free survival , confidence interval , leukemia , chemotherapy